How does the COVID-19 pandemic compare to other infamous viral infections that have plagued us in modern times? It’s a question that’s been asked repeatedly in social media circles in recent weeks as people struggle to gain a better understanding of what we are facing.
Recently, I received an answer that was terrifying.
The subject was raised during a March 18 webinar featuring Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases. He is the nation’s top infectious disease expert, who was described recently by the Washington Post as the “grandfatherly captain of the coronavirus crisis”.
Dr. Fauci was asked by the editor of the Journal of the American Medical Association to put the virus in historical context. His response:
In my 40 years at the NIH, I’ve never seen anything like this. It is totally unique. We’ve been through emerging infectious diseases and in some cases crises, like we had with the anthrax scare back in 2001, Ebola virus, the early years of HIV, the scares of influenza pandemics. But nothing of this magnitude.
HIV evolved slowly, even though it turned out to be a terrible affront to human civilization, with a lot of suffering and death. Many other threats didn’t materialize here. Although there was a lot of concern about Ebola, there was never the serious concern of a widespread outbreak in the US, although there have been several devastating epidemics in African countries.
The comparison inspired me to look back at the US experience with HIV, anthrax, and Ebola hemorrhagic fever. (Influenza is covered here.)
HIV: A slower trajectory, harder to contract
I remember the beginnings of the HIV/AIDS pandemic well. I followed it through the Morbidity and Mortality Weekly Report, a small, square newsletter from the CDC that sparked many of my ideas as a fledgling science writer.
The first entry in the June 5, 1981, MMWR was unusual.
“5 gay men with Pneumocystis carinii pneumonia (PCP) in LA, reported from October 1980-May 1981.”
Nearly a year later, on May 11, 1982, as cases had quietly mounted, “New Homosexual Disorder Worries Health Officials“ ran in The New York Times. The article referred to “Gay-Related Immune Deficiency,” or GRID, a term circulating at the time.
Image Credit: Xiao Yijiu/Associated Press
News This Week
Doctors may be missing signs of serious and potentially fatal brain disorders triggered by coronavirus, as they emerge in mildly affected or recovering patients, scientists have warned. Neurologists are on Wednesday publishing details of [...]
University of Wisconsin-Madison researchers have developed a safer and more efficient way to deliver a promising new method for treating cancer and liver disorders and for vaccination -- including a COVID-19 vaccine from Moderna [...]
Despite its advantages over other vaccine technologies for Covid-19, adenovirus vector vaccines are likely to be tripped up by pre-existing antibodies to the vectors used and the need for a second injection to boost [...]
When the first coronavirus cases in Chicago appeared in January, they bore the same genetic signatures as a germ that emerged in China weeks before. But as Egon Ozer, an infectious-disease specialist at the Northwestern University [...]
Park Systems presents “NanoScientific Symposium on Nano Applications for a Changing World” sponsored by Physics World and Nanotechnology World Association. Park Systems launched this online event for researchers and scientists in nanoscience and nanotechnology [...]
Notwithstanding the wishful thinking of certain irresponsible and incompetent public figures, the only options to control and deal with the spread of the Severe Acute Respiratory Syndrome Virus 2 (SARS-CoV-2) are fast, cheap, reliable, [...]
From the Annals of Neurology: In less than 6 months, the severe acute respiratory syndrome‐coronavirus type 2 (SARS‐CoV‐2) has spread worldwide infecting nearly 6 million people and killing over 350,000. Initially thought to be restricted [...]
A cheap steroid has become the first life-saving treatment in the Covid-19 pandemic, described by scientists as a major breakthrough and raising hopes for the survival of thousands of the most seriously ill. Dexamethasone [...]
Clinical researchers are this week set to begin human trials of a new coronavirus vaccine developed by researchers at Imperial College London. The study will be the first time the vaccine has been trialled in humans [...]
A form of the novel coronavirus which has become the dominant type in much of the world may have done so thanks to a mutation that allows it to better latch onto human hosts’ [...]
A widely available and inexpensive drug that is used to ease the symptoms of indigestion may prove a worthy contender for treating COVID-19 infection in those whose disease doesn’t require admission to hospital, suggest [...]
One of the most common COVID-19 tests involves a long swab pressed deep into the nasal cavities – and while the test can be administered quickly, it has been described as unpleasant and uncomfortable. [...]
Nature wades through the literature on the new coronavirus — and summarizes key papers as they appear: 1 June — Positive coronavirus test is no guarantee of infectiousness People with COVID-19 are unlikely to [...]
In April, blood clots emerged as one of the many mysterious symptoms attributed to Covid-19, a disease that had initially been thought to largely affect the lungs in the form of pneumonia. Quickly after came [...]
Scientists from the University of Maryland School of Medicine (UMSOM) developed an experimental diagnostic test for COVID-19 that can visually detect the presence of the virus in 10 minutes. It uses a simple assay [...]
Rheumatologists at the University of Alberta are flagging similarities between the deaths of some COVID-19 patients and those with rheumatic illnesses, and are testing proven rheumatic treatments to see whether they help against [...]